Indee Labs

About:

Indee Labs is unlocking gene-modified cell therapy for the masses with scalable hardware for gene delivery.

Twitter/X: indeelabs

Top Investors: IndieBio, Y Combinator, Bossanova Investimentos, Founders Fund, National Institute of Allergy and Infectious Diseases

Description:

Indee Labs is developing hardware for gene delivery. Our hardware is uniquely positioned for the efficient development and scalable manufacture of gene-modified cell therapies such as chimeric antigen receptor T cells. The technology is being developed with the help of the Australian National Fabrication Facility. We are alumni of NSW Health, IndieBio, Y Combinator and MBC Biolabs (née QB3@953). We are opening up an office in Sydney and have lab space at Bonneville Labs in Berkeley.

Total Funding Amount:

$5.06M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

San Francisco, California, United States

Founded Date:

2015-08-01

Contact Email:

hello(AT)indeelabs.com

Founders:

Ryan Pawell

Number of Employees:

1-10

Last Funding Date:

2023-06-06

IPO Status:

Private

Industries: